期刊文献+
共找到2,460篇文章
< 1 2 123 >
每页显示 20 50 100
Analysis of Pesticide Raid^(█) in Feed of Wistar Rat by High-Pressure Liquid Chromatography (HPLC)
1
作者 Albert C. Achudume 《American Journal of Analytical Chemistry》 2011年第8期32-36,共5页
The distribution of pesticide by-product in tissues of wistar rats were analyzed using high pressure liquid chromatography. The limit of detection of the HPLC was 0.1 μg. Results show bioaccumulation factor of pestic... The distribution of pesticide by-product in tissues of wistar rats were analyzed using high pressure liquid chromatography. The limit of detection of the HPLC was 0.1 μg. Results show bioaccumulation factor of pesticide “Raid?” in lipid, up to three times that of the feed at the first concentration and gradually decreased as the concentration increased in the muscle > (0.7), brain > (0.5) and liver > (0.3) as indicated in the text. At higher concentration of 961 μg/g, bioaccumulation factor decreased in the lipid to 1.2 and 0.6 in the muscle, 0.03 in the brain and 0.08 in the liver respectively. High Pressure Liquid Chromatography (HPLC) analysis of raid extract suggests the presence of micprothrin and palethrin. The implications are numerous, but simply put that accidental ingestion of chlorinated hydrocarbon as in “Raid?” may involve convulsions, collapse and coma after only brief excitation and ataxia at the onset. 展开更多
关键词 high pressure liquid chromatography PESTICIDE Raid^(█) Chlorinated Hydrocarbon BIOACCUMULATION
下载PDF
Sensitive determination of 4-O-methylhonokiol in rabbit plasma by high performance liquid chromatography and application to its pharmacokinetic investigation
2
作者 Ming-Yue Li Yu-Hai Tang Xia Liu Hai-Yan Lu Xi-Yan Shi 《Journal of Pharmaceutical Analysis》 SCIE CAS 2011年第2期108-112,共5页
A novel high performance liquid chromatographic method was developed for the determination of 4-O- methylhonokiol in rabbit plasma and was applied to its pharmacokinetic investigation. Plasma samples were treated by o... A novel high performance liquid chromatographic method was developed for the determination of 4-O- methylhonokiol in rabbit plasma and was applied to its pharmacokinetic investigation. Plasma samples were treated by one-fold volume of methanol and acetonitrile to remove the interference proteins. A reverse phase column of SHIM- PACK VP-ODS (150 mm × 4.6 mm, 5.0 μm) was used to separate 4-O-methylhonokiol in the plasma samples. The detection limit of 4-O-methylhonokiol was 0.2 μg/L and the linear range was 0. 012 - 1. 536 mg/L. The good extraction recoveries were obtained for the spiked samples (84.7%, 89.3% and 87.7% for low, middle and high concentrations of added standards, respectively). The relative standard deviation of intra-day and inter-day precisions was in the range from 0.6% to 13.5%. The pharmacokinetic study of 4-O-methylhonokiol was made and the results from the plasmaconcentration curve of 4-0-methylhonokiol showed a two-apartment open model. This work developed a sensitive, stable and rapid HPLC method for the determination of 4-O-methylhonokiol and the developed method has been successfully applied to a pharmacokinetic study of 4-O-methylhonokiol. 展开更多
关键词 4-O-methylhonokiol Cortex Magnoliae Officinalis high performance liquid chromatography pharmacokinetIC
下载PDF
Quantitative determination of ilexgenin A in rat plasma by liquid chromatography coupled with mass spectrometry and its pharmacokinetics 被引量:2
3
作者 柳文媛 李萍 +2 位作者 冯锋 余成霞 丁黎 《Journal of Chinese Pharmaceutical Sciences》 CAS 2010年第1期38-42,共5页
A sensitive and selective high performance liquid chromatography coupled with electrospray ionization mass spectrometry (LC-MS) was developed for the quantitative determination of ilexgenin A (IA),a major componen... A sensitive and selective high performance liquid chromatography coupled with electrospray ionization mass spectrometry (LC-MS) was developed for the quantitative determination of ilexgenin A (IA),a major component in Radix Ilicis Pubescentis,in rat plasma.Chromatographic separation was performed on a C 18 column,with methanol-5 mM ammonium acetate (80:20,v/v) as the mobile phase.Mass spectrometer was set in negative mode with target ions at m/z 501.1→501.1 for IA and m/z 779.4→779.4 for digoxin (internal standard,IS).Rat plasma was extracted with ethyl acetate after addition of phosphoric solution and the organic layer was evaporated and reconstituted with mobile phase for LC-MS analysis.The proposed method was validated with a linear range of 1.05-525.5 ng/mL for IA with limit of quantitation (LOQ) at 1.05 ng/mL.Intra-and inter-day precision expressed as relative standard deviation (RSD) were less than 10% at LOQ level and overall recovery was over 80%.This validated method was used successfully for the pharmacokinetic study of IA in rats after oral dosing of IA (100 mg/kg) and some main pharmacokinetic parameters of IA in rats were obtained. 展开更多
关键词 high performance liquid chromatography Electrospray ionization mass spectrometry Ilexgenin A Radix Ilicis Pubescentis pharmacokinetic study
原文传递
Plasma amino acid profiling of cancer patients with abnormal Savda based on high-performance liquid chromatography 被引量:1
4
作者 Batur Mamtimin Kedena +5 位作者 Bin Kong Ayshamgul Hasim Aynur Matsidik Mawlanjan Hizbulla Nazuk Kurbantay Halmurat Upur 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2014年第5期560-565,共6页
OBJECTIVE: To investigate metabolic signatures in plasma of cancer patients with abnormal Savda using plasma-free amino acid profiles, and to evaluate the diagnostic potential of these profiles for the detection and e... OBJECTIVE: To investigate metabolic signatures in plasma of cancer patients with abnormal Savda using plasma-free amino acid profiles, and to evaluate the diagnostic potential of these profiles for the detection and explanation of the mechanisms of different symptoms in traditional Uyghur medicine.METHODS: Plasma samples from cancer patients with abnormal Savda(n=85) or non-abnormal Savda(n=105) and a healthy control group(n=65)were analyzed using high-performance liquid chromatography(HPLC). Orthogonal projection to latent structures with discriminant analysis was used for the classification and prediction of abnormal Savda, and spectral profiles were subjected to Student's t-tests to assess statistical significance.RESULTS: Compared with the healthy group, the levels of aspartic acid, glutamate, glycine, histidine,arginine, threonine, alanine, proline, methionine,isoleucine, leucine and phenylalanine decreased significantly in plasma of cancer patients with abnormal Savda(all P<0.05). Serine, cystine, tyrosine,valine and lysine levels showed no significant differences(all P>0.05). Compared with non-abnormal Savda syndrome patients, abnormal Savda syndrome patients showed high concentrations of glutamate, serine, valine, isoleucine, leucine and phenylalanine(all P<0.05). The remaining plasma amino acids showed no significant differences(all P>0.05).CONCLUSION: Plasma-free amino acid profiling has the potential to assist in understanding and determining abnormal Savda. A HPLC-based metabonomic platform could be a powerful tool for the classification of symptoms in traditional medicine. 展开更多
关键词 Amino acids Medicine Uyghur tradi-tional chromatography high pressure liquid Ab-normal Savda
原文传递
Research on pharmacokinetics of high-dose tamoxifen in non-small cell lung cancer patients
5
作者 陈玲 李旭 +4 位作者 李蓉 赵新汉 李睿 郑晓辉 王嗣岑 《Journal of Pharmaceutical Analysis》 SCIE CAS 2007年第2期204-207,共4页
Objective To study the pharmacokinetics of tamoxifen at a high dosage, which will offer a theoretical support for an appropriate clinical use of the medicine in non-small cell lung cancer (NSCLC) patients. Methods Thr... Objective To study the pharmacokinetics of tamoxifen at a high dosage, which will offer a theoretical support for an appropriate clinical use of the medicine in non-small cell lung cancer (NSCLC) patients. Methods Three qualified NSCLC patients are selected and given tamoxifen (TAM) 160 mg per Os. Blood samples were collected at different times and then analyzed by high-performance liguid chromatography. The PK-GRAPH program was used to obtain the parameters. Results The concentration-time courses of the TAM 160 mg were fitted to one-compartment model. The pharmacokinetic parameters were estimated as follows: Tmax (6.35±1.24)h, Cmax (217.39±7.71)ng/mL, AUC (12 127.39±636.16)ng·h/mL and T1/2ke (34.13±2.97)h. Conclusion TAM 160mg one day per Os cannot reach the effective maintenance concentration in vivo required for reversing MDR in vitro. Loading-maintenance dose strategy is recommended to study the pharmacodynamics of tamoxifen at a high dosage in NSCLC patients. 展开更多
关键词 TAMOXIFEN pharmacokinetics high-performance liquid chromatography non-small cell lung cancer resistance to drug
下载PDF
Pharmacokinetics of Oxiracetam in Healthy Volunteers 被引量:6
6
作者 魏春敏 王本杰 郭瑞臣 《Journal of Chinese Pharmaceutical Sciences》 CAS 2005年第1期29-32,共4页
Aim To study the pharmacokinetics of oxiracetam after single and multipleintravenous administrations in healthy volunteers. Method A HPLC method was used to determine theserum concentration of oxiracetam after intrave... Aim To study the pharmacokinetics of oxiracetam after single and multipleintravenous administrations in healthy volunteers. Method A HPLC method was used to determine theserum concentration of oxiracetam after intravenous single dose and daily dose of 2 000 mg for 7 din ten Chinese healthy volunteers. Pharmacokinetic analysis was carried out using Drug And Statisticsoftware. Results The AUC_(0-12), AUC_(0-∞), K_e, t_(1/2), MRT after a single dose of 2 000 mgoxiracetam were 256.26 ± 16.84 μg·mL^(-1)·h, 276.74 ±18.11 μg·mL^(-1)·h, 0.18 ±0.03 h^(-1),3.84±0.64 h, and 4.39 10.39 h, and after multiple doses of oxiracetam were 259.36 ±25.43μg·mL^(-1)·h, 285.59 ±27.38 μg·mL^(-1)·h, 0.17 ±0.04 h^(-1), 4.14 ± 0.82 h, and 4.87 ±0.69 h, respectively. Conclusion The pharmacokinetic parameters of oxiracetam do not differremarkably after single and multiple intravenous administration and there is accumulation in serumafter 2 000 mg multiple intravenous administration once a day fof 7 d. 展开更多
关键词 OXIRACETAM high performance liquid chromatography pharmacokinetIC
下载PDF
Preparation of stealthy etoposide proliposomes and the pharmacokinetics in rabbits
7
作者 李津明 张彦卓 +1 位作者 任君刚 曲韵志 《Journal of Chinese Pharmaceutical Sciences》 CAS 2008年第4期303-308,共6页
The objectives of the present study were to prepare stealthy etoposide proliposomes and study the pharmacokinetics in rabbits. Blank stealthy liposomes were prepared by film dispersion method. Stealthy etoposide lipos... The objectives of the present study were to prepare stealthy etoposide proliposomes and study the pharmacokinetics in rabbits. Blank stealthy liposomes were prepared by film dispersion method. Stealthy etoposide liposomes were prepared by using the ammonium sulfate gradient loading procedure. Vacuum freeze-drying technique was used to dry stealthy etoposide liposomes. Encapsulation efficiency of stealthy etoposide proliposomes was determined by Sephadex chromatography. The morphology was observed by transmission electronic microscope. The particle size and zeta potential were measured by using electrophoretic light scattering technology. The pharmacokinetics in rabbits was evaluated by comparison with etoposide injection and conventional liposomes, respectively. Mean encapsulation efficiency of stealthy etoposide proliposomes was 83.92% ± 3.65% (n = 3). The liposomes were round or oval. Mean particle size was (124.5 ±26.9) nm, and zeta potential was (-39.50 ±1.04) mV. Following intravenous injection administration at a dose of 1.5 mg/kg etoposide, the three kinds of etoposide preparations were fitted with the two-compartment model. T1/2 β and A UC values of stealthy etoposide proliposomes were (19.26 ± 3.16) h and (26.04 ±3.53) μg/h/mL, respectively. T1/2 β and AUC values of etoposide injection were (0.94 ± 0.21) h and (0.98 ± 0.26) μg/h/mL, respectively. T1/2β and AUC values of conventional liposomes were (7.99 ± 1.36) h and (11.65 ± 1.70) μg/h/mL, respectively. Results indicated that the stealthy etoposide proliposomes could significantly extend the duration of etoposide in blood circulation. 展开更多
关键词 Etoposide Stealthy proliposomes high performance liquid chromatography pharmacokinetics
下载PDF
Pharmacokinetics of intravenously administered sodium dichloroacetate in rabbits
8
作者 顾斌 宋岭 +2 位作者 蒋永培 文爱东 王纪保 《Journal of Medical Colleges of PLA(China)》 CAS 1994年第4期306-308,共3页
PharmacokineticsofintravenouslyadministeredsodiumdichloroacetateinrabbitsGuBin(顾斌);SongLing(宋岭);JiangYongpei... PharmacokineticsofintravenouslyadministeredsodiumdichloroacetateinrabbitsGuBin(顾斌);SongLing(宋岭);JiangYongpei(蒋永培);WenAidong(文... 展开更多
关键词 pharmacokinetics DICHLOROACETATE high performance liquid chromatography RABBITS
下载PDF
Relationship between cardiotonic activity of Fuzi(Radix Aconiti Lateralis Preparata)and its fingerprint determined by liquid chromatography-mass spectrometry
9
作者 TONG Hengli ZHU Jing +2 位作者 ZHONG Lingyun XU Ting GONG Feipeng 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2021年第1期140-149,共10页
OBJECTIVE:To investigate the relationship between the cardiotonic activity of Fuzi(Radix Aconiti Lateralis Preparata,RALP)and its fingerprint determined by liquid chromatography-mass spectrometry(LC-MS).METHODS:First,... OBJECTIVE:To investigate the relationship between the cardiotonic activity of Fuzi(Radix Aconiti Lateralis Preparata,RALP)and its fingerprint determined by liquid chromatography-mass spectrometry(LC-MS).METHODS:First,the fingerprints of six processed products of RALP were established by high performance liquid chromatography quadrupole time-of-flight mass spectrometry(HPLC-Q-TOF-MS)followed by analysis of the principal component of the relative peak area of its common peaks.Next,the scores of the first five principal components were used as input for an artificial neural network(ANN).Additionally,the therapeutic effect of RALP was assessed by measuring the hemodynamic indexes of heart failure model rats.Subsequently,fluorescence semi-quantitative polymerase chain reaction and an enzyme-linked immunosorbent assay kit were used to determine the effects of RALP-processed products on the serum levels of noradrenaline(NA),angiotensin-Ⅰ(Ang-Ⅰ),and the expression ofβ-norepinephrine receptor m RNA(β-NRm)in the rat cardiac tissues.P<0.05 was used as the output of the ANN.Finally,a network was constructed to display the relationship between the LC-MS fingerprints and the cardiotonic activity of the RALP-processed products.RESULTS:Several types of RALPs can improve diastolic function,systolic function and heart rate.On the basis of the findings from the principal component analysis(PCA)of 16 common peaks of fingerprints of six RALP-processed products,it was revealed that the first five principal components may include 100%of the information of the original data.As observed from the multilayer perceptron neural network analysis,principal component 4 presented with the strongest effects on serum levels of NA and Ang-Ⅰin rats,while principal component1 exerted the greatest effect onβ-NRm expression in cardiac tissue.CONCLUSION:The key findings obtained from this study indicated that the network constructed by the PCA-ANN may predict pharmacodynamic effects of the main ingredients of Traditional Chinese Medicine(TCM).This method may serve as a new approach to identify the relationship between LC-MS fingerprints and the pharmacodynamic effects of TCM ingredients. 展开更多
关键词 chromatography high pressure liquid Mass spectrometry Principal component analysis Radix Aconiti Lateralis Preparata GINGER Artificial neural network
原文传递
阿莫西林胶囊在中国健康人体内的生物等效性研究 被引量:2
10
作者 卢俊丽 刘婉莹 +7 位作者 李灿霞 黄丽凤 张婵娟 李艳波 雷雨燕 陈露露 欧阳冬生 颜羽 《广西医科大学学报》 CAS 2024年第1期98-103,共6页
目的:研究阿莫西林胶囊在中国健康人体内的生物等效性。方法:以单中心、开放式、随机、双制剂、两周期、两序列交叉试验设计,共48例受试者(空腹试验和餐后试验各24例),口服0.25 g阿莫西林胶囊受试制剂或参比制剂。高效液相色谱—串联质... 目的:研究阿莫西林胶囊在中国健康人体内的生物等效性。方法:以单中心、开放式、随机、双制剂、两周期、两序列交叉试验设计,共48例受试者(空腹试验和餐后试验各24例),口服0.25 g阿莫西林胶囊受试制剂或参比制剂。高效液相色谱—串联质谱(LC-MS/MS)分析方法测定给药后不同时间阿莫西林的血药浓度,并计算主要药代动力学参数,判定两制剂是否等效。结果:空腹试验显示,受试制剂和参比制剂阿莫西林的药物峰浓度(C_(max))分别为(5483.296±1321.102)ng/mL、(5611.291±1659.407)ng/mL,从时间0到t之间血药浓度—时间曲线下面积(AUC_(0-t))分别为(13255.3±1715.7)h·ng/mL、(13115.5±2091.7)h·ng/mL,从0时到无限时间(∞)的血药浓度—时间曲线下面积(AUC_(0-∞))分别为(13329.4±1718.8)h·ng/mL、(13192.7±2107.1)h·ng/mL,达峰时间(T_(max))均为1.38 h。餐后试验显示,受试制剂和参比制剂阿莫西林的C_(max)分别为(4218.072±780.598)ng/mL、(4156.713±877.752)ng/mL,AUC_(0-t)分别为(13073.9±1584.3)h·ng/mL、(12817.8±1575.5)h·ng/mL,AUC_(0-∞)分别为(13166.8±1606.0)h·ng/mL、(12914.8±1587.2)h·ng/mL,T_(max)均为3.00 h。两种试验制剂C_(max)、AUC_(0-t)、AUC_(0-∞)几何均值比值的90%置信区间(CI)均在可接受的生物等效性范围内(80%~125%)。结论:两种阿莫西林胶囊在中国健康志愿者体内吸收速度和吸收程度生物等效。 展开更多
关键词 阿莫西林 生物等效性 药代动力学 高效液相色谱—串联质谱
下载PDF
艾司奥美拉唑对对乙酰氨基酚药动学与肠道菌群的影响
11
作者 贾茹 王怡帆 +4 位作者 陈文华 张文萍 贺少龙 党宏万 魏世杰 《医药导报》 CAS 北大核心 2024年第6期862-866,共5页
目的探讨质子泵抑制剂(PPI)艾司奥美拉唑(EMZ)对对乙酰氨基酚(APAP)药动学与肠道菌群生态平衡的作用。方法将14只SD大鼠随机分为2组,分别为APAP组、APAP+EMZ组,每组7只;将APAP+EMZ组大鼠置于代谢笼中饲养。APAP+EMZ组灌胃给予EMZ 3.6 mg... 目的探讨质子泵抑制剂(PPI)艾司奥美拉唑(EMZ)对对乙酰氨基酚(APAP)药动学与肠道菌群生态平衡的作用。方法将14只SD大鼠随机分为2组,分别为APAP组、APAP+EMZ组,每组7只;将APAP+EMZ组大鼠置于代谢笼中饲养。APAP+EMZ组灌胃给予EMZ 3.6 mg·kg^(-1)·d^(-1),APAP组以等体积0.9%氯化钠溶液代替,连续灌胃14 d;分别在给予EMZ前和给药14 d后收集大鼠粪便进行微生物16SrRNA测序。第15天APAP组和APAP+EMZ组灌胃EMZ后同法给予APAP 44.82 mg·kg^(-1)。超高效液相色谱-串联质谱(UPLC-MS/MS)法测定样品中APAP浓度。计算药动学参数并统计分析,比较APAP组和APAP+EMZ组APAP药动学参数。结果①两组APAP的达峰浓度(C max)比较差异有统计学意义(P<0.05),与APAP组比较,APAP+EMZ组C max增加120.38%。两组血药浓度-时间曲线下面积(AUC_((0-∞)))、清除率(CL)、消除半衰期(t_(1/2))和达峰时间(t_(max))比较均差异无统计学意义(均P>0.05);②使用EMZ后乳酸杆菌属、拟杆菌属、梭状芽孢杆菌属和埃希杆菌属相对丰度较用药前减少,而双歧杆菌属增加。但上述菌群相对丰度在EMZ干预前后差异无统计学意义(P>0.05)。结论EMZ与APAP联用时,影响β-葡萄糖醛酸苷酶的菌群相对丰度有一些变化,EMZ对APAP的C_(max)有影响;使用EMZ 2周不通过影响肠道菌群而改变APAP的药动学。 展开更多
关键词 对乙酰氨基酚 艾司奥美拉唑 超高效液相色谱-串联质谱 药动学 肠道菌群
下载PDF
同时测定复方四维女贞子胶囊中维生素B_(1)和维生素B_(6)的含量
12
作者 曹桂红 杜启露 +2 位作者 刘璐 许波 王璐 《山东化工》 CAS 2024年第14期162-165,169,共5页
目的:建立高效液相色谱法测定复方四维女贞子胶囊中维生素B_(1)和维生素B_(6)的含量。方法:采用C 18(4.6 mm×250 mm,5μm)色谱柱,以乙腈-庚烷磺酸钠溶液(0.32 g庚烷磺酸钠,加水800 mL溶解,加三乙胺2 mL,冰醋酸10 mL,加水稀释至1000... 目的:建立高效液相色谱法测定复方四维女贞子胶囊中维生素B_(1)和维生素B_(6)的含量。方法:采用C 18(4.6 mm×250 mm,5μm)色谱柱,以乙腈-庚烷磺酸钠溶液(0.32 g庚烷磺酸钠,加水800 mL溶解,加三乙胺2 mL,冰醋酸10 mL,加水稀释至1000 mL)(体积比7∶93)为流动相,流速:1.0 mL/min,检测波长:274 nm,柱温为40℃,进样体积10μL。结果:维生素B_(1)在0.4988~99.76μg范围内线性关系良好,回归方程Y=12976x-2190.4(R 2=1);维生素B_(6)在0.4822~96.44μg范围内线性关系良好,回归方程Y=11071x+1567(R 2=1);维生素B_(1)回收率为100.76%(n=9),RSD为0.7%;维生素B_(6)回收率为99.51%(n=9),RSD为0.8%。结论:该方法简便、快速、准确,为复方四维女贞子胶囊中维生素B_(1)和维生素B_(6)的含量测定提供了科学的测定方法。 展开更多
关键词 高效液相色谱法 复方四维女贞子胶囊 维生素B_(1) 维生素B_(6) 含量测定
下载PDF
超高效液相色谱串联质谱测定儿童血液样本中高三尖杉酯碱含量
13
作者 袁树伟 杜小换 +3 位作者 张先明 花盛浩 胡绍燕 朱增燕 《儿科药学杂志》 CAS 2024年第3期16-19,共4页
目的:建立并验证超高效液相色谱串联质谱(UPLC-MS/MS)测定儿童血液样本中高三尖杉酯碱含量的方法。方法:以Waters Xevo TQD为检测设备,Waters BEH C18(100 mm 2.1 mm,1.7μm)为色谱柱,采用甲醇为有机相,含0.1%甲酸的超纯水为无机相,进... 目的:建立并验证超高效液相色谱串联质谱(UPLC-MS/MS)测定儿童血液样本中高三尖杉酯碱含量的方法。方法:以Waters Xevo TQD为检测设备,Waters BEH C18(100 mm 2.1 mm,1.7μm)为色谱柱,采用甲醇为有机相,含0.1%甲酸的超纯水为无机相,进行梯度洗脱,质谱检测采用正离子,多重反应监控(MRM)模式,待测物高三尖杉酯碱(HHT)离子通道m/z 546.3→298.2,内标物三尖杉酯碱(HT)离子通道m/z 532.2→298.3,锥孔电压50 V,碰撞能量28 V。结果:本方法样本前处理简单,分析速度快,结果具有较高的选择性和灵敏度,线性区间0.5~120.0 ng,线性方程Y=0.0470113X+0.0070358(r=0.9991),定量下限0.5 ng,日内精密度RSD<8.16%,日间精密度RSD<6.38%,准确度94.00%~103.95%。结论:本方法选择性好、灵敏度高,可应用于儿童体内HHT的药动学研究和血药浓度监测等相关工作。 展开更多
关键词 超高效液相色谱串联质谱 高三尖杉酯碱 药代动力学
下载PDF
心肌缺血再灌注损伤大鼠体内荭草花活性成分的PK-PD研究
14
作者 杨青波 杨兴美 +4 位作者 向文英 郑林 黄勇 迟明艳 蒲健 《贵州医科大学学报》 CAS 2024年第7期966-974,共9页
目的建立药代动力学-药效动力学(PK-PD)结合模型,探讨荭草花提取物在心肌缺血再灌注损伤(MIRI)模型大鼠体内活性成分的动态变化与其药效消长之间的关系。方法荭草花药材经水煮醇沉、正丁醇萃取得荭草花提取物;取SD大鼠6只,采用冠脉结扎... 目的建立药代动力学-药效动力学(PK-PD)结合模型,探讨荭草花提取物在心肌缺血再灌注损伤(MIRI)模型大鼠体内活性成分的动态变化与其药效消长之间的关系。方法荭草花药材经水煮醇沉、正丁醇萃取得荭草花提取物;取SD大鼠6只,采用冠脉结扎法制备MIRI模型,术前大鼠灌胃荭草花提取物86 g/kg,3次/d、连续5 d,于末次给药后5 min、10 min、15 min、30 min、1.0 h、1.5 h、2.0 h、4.0 h、6.0 h、8.0 h、10.0 h、12.0 h、24.0 h、36.0 h及48.0 h经尾静脉取血,采用高效液相色谱-串联质谱(HPLC-MS/MS)检测血浆样本中6种活性成分(原儿茶酸、槲皮苷、花旗松素、N-p香豆酰酪胺、山奈素-3-O-β-D-葡萄糖苷及山奈素-3-O-α-L-鼠李糖苷)的质量浓度,获取各成分血药浓度-时间曲线;采用试剂盒测定血浆样本中超氧化物歧化酶(SOD)、乳酸脱氢酶(LDH)、肌酸激酶同工酶(CK-MB)及心肌钙蛋白I(cTn-I)的浓度,获取效应-时间曲线;通过Winnonlin 6.4软件分别对药物浓度-时间与效应-时间进行拟合,建立PK-PD模型。结果荭草花提取物中各有效成分均能够较好地与各药效指标拟合,以SOD为药效指标时,各成分的PK-PD模型以Sigmoid E_(max)拟合较优;以LDH、CK-MB及cTn-I为药效指标时,各成分的PK-PD模型以Inhibitory Effect拟合较优。结论荭草花提取物中的原儿茶酸、槲皮苷、山奈素-3-O-β-D-葡萄糖苷及山奈素-3-O-α-L-鼠李糖苷、花旗松素、N-p香豆酰酪胺具有心肌缺血保护作用,其浓度与药效指标SOD、LDH、CK-MB及cTn-I的水平有相关性。 展开更多
关键词 心肌缺血 再灌注损伤 药代动力学 荭草花提取物 高效液相色谱-串联质谱 药效动力学 PK-PD模型 活性成分 药效指标
下载PDF
2-脱氧葡萄糖修饰共载siPD-L1及替莫唑胺脂质纳米粒的脑靶向性研究 被引量:2
15
作者 罗静远 杨静 +2 位作者 李雪 周四元 刘道洲 《空军军医大学学报》 CAS 2024年第1期73-79,共7页
目的考察2脱氧葡萄糖(2-DG)修饰共载siPD-L1及替莫唑胺(TMZ)脂质纳米粒(TMZ/siPD-L1@GLPN)在小鼠体内的药物动力学及脑内分布,阐明TMZ/siPD-L1@GLPN的脑靶向性,为脑靶向递药系统的设计提供依据。方法采用高效液相色谱及活体成像仪考察游... 目的考察2脱氧葡萄糖(2-DG)修饰共载siPD-L1及替莫唑胺(TMZ)脂质纳米粒(TMZ/siPD-L1@GLPN)在小鼠体内的药物动力学及脑内分布,阐明TMZ/siPD-L1@GLPN的脑靶向性,为脑靶向递药系统的设计提供依据。方法采用高效液相色谱及活体成像仪考察游离TMZ、TMZ/siPD-L1@GLPN以及未经2-DG修饰共载siPD-L1及TMZ脂质纳米粒(TMZ/siPD-L1@LPN)小鼠尾静脉给药后,TMZ在血浆中的消除动力学以及在小鼠脑内的分布动力学。结果与游离TMZ相比,TMZ/siPD-L1@GLPN在小鼠血浆中的消除速度明显减缓,TMZ/siPD-L1@GLPN在小鼠体内的循环时间明显延长。游离TMZ、TMZ/siPD-L1@GLPN以及TMZ/siPD-L1@LPN给药后,TMZ在血浆中的AUC 0~∞分别为(139.49±14.39)、(585.50±44.91)和(705.73±173.02)h/(mg·L),TMZ在脑组织中的AUC 0~∞分别为(32.39±3.12)、(532.89±46.44)和(162.79±18.38)h/(mg·kg)。活体成像仪观察结果显示,相较于TMZ/siPD-L1@LPN,TMZ/siPD-L1@GLPN在脑内的分布更多。结论2-DG修饰脂质纳米粒后能够显著提高脂质纳米粒的脑靶向性,显著延长TMZ在小鼠体内的循环时间。 展开更多
关键词 替莫唑胺 药代动力学 脑胶质瘤 高效液相色谱 活体成像
下载PDF
黄芩不同炮制品黄酮类成分的整合药动学研究
16
作者 宋亚南 王云 +2 位作者 陈影 黄琪 张村 《世界中医药》 CAS 北大核心 2024年第17期2552-2561,2571,共11页
目的:比较黄芩炮制品中8种黄酮类成分在大鼠体内含量的差异,探明黄芩不同炮制品的药动学行为的差异,为其炮制原理的阐明提供科学依据。方法:选取20只SD大鼠随机分为空白组、生黄芩、酒黄芩和黄芩炭4组,每组5只,灌胃给药。以山柰素为内标... 目的:比较黄芩炮制品中8种黄酮类成分在大鼠体内含量的差异,探明黄芩不同炮制品的药动学行为的差异,为其炮制原理的阐明提供科学依据。方法:选取20只SD大鼠随机分为空白组、生黄芩、酒黄芩和黄芩炭4组,每组5只,灌胃给药。以山柰素为内标,采用超高效液相色谱-三重四级杆串联质谱法(UPLC-QQQ-MS/MS)测定不同时间点大鼠血清中黄芩苷、5,7,2′,5′-四羟基-8,6′-二甲氧基黄酮(HQ-6)、汉黄芩苷、黄芩素、汉黄芩素、白杨素、5,6-二羟基-7,8,2′,6′-四甲氧基黄酮(HQ-2)、千层纸素-A等的浓度,利用各成分药-时曲线下面积(AUC_(0→∞))百分比作为自定义权重系数,计算在大鼠体内的综合血药浓度并建立整合药物代谢动力学(药动学)模型,比较黄芩炮制品中黄酮类成分的整合药动学参数的差异。结果:单成分的AUC_(0→∞)差异较大;多成分整合药动力学结果显示,黄芩酒炙后,8种黄酮类成分的滞留时间(MRT_(0→∞))由17.22 h缩短为13.13 h。首次达峰时间(T_(max))由0.50 h缩短为0.25 h,2次(T_(max))由4 h延长为8 h。黄芩炒炭后,黄芩炭的多成分整体的MRT_(0→∞)为10.07 h,与酒黄芩比较,差异无统计学意义(P>0.05)。黄芩炭存在0.25、1、2 h,3次达峰。结论:该方法专属性强、灵敏度高,可作为大鼠血清中8种黄酮类成分的同步检测及其药动学研究的方法,进一步诠释了黄芩“酒炙增效,炒炭存性”的科学内涵。 展开更多
关键词 黄芩 酒黄芩 黄芩炭 黄酮 整合药动学 炮制 超高效液相色谱-三重四级杆串联质谱法
下载PDF
Determination of S/R ratio of mephenytoin in human urine by chiral HPLC and ultraviolet detection and its comparison with gas chromatography 被引量:4
17
作者 黄松林 谢红光 +3 位作者 王伟 许振华 蒋长虹 周宏灏 《中国药理学报》 CSCD 1998年第6期548-550,共3页
目的:建立人尿中R,S美芬妥英的液相色谱手性分离与检测方法,用于CYP2C19酶活性的快速测定.方法:受试者口服消旋美芬妥英后的0-8h尿液标本用二氯甲烷提取后用手性色谱柱进行分离,流动相为乙腈和水(14∶86,体... 目的:建立人尿中R,S美芬妥英的液相色谱手性分离与检测方法,用于CYP2C19酶活性的快速测定.方法:受试者口服消旋美芬妥英后的0-8h尿液标本用二氯甲烷提取后用手性色谱柱进行分离,流动相为乙腈和水(14∶86,体积比),其中含有0.1%的冰醋酸和0.2%的三乙胺,流速为0.9mL·min-1,紫外检测波长为207nm.结果:在选定的色谱条件下R,S美芬妥英能很好地分离,尿中其他物质无干扰.用外标法定量,线性范围在50-5000μg·L-1,最小检出浓度为12.5μg·L-1,保留时间在9min内.液相色谱分析结果和气相色谱分析具有良好的一致性.结论:该法样本制备简便、分析时间短、线性范围宽、干扰少、灵敏和准确。 展开更多
关键词 美芬妥英 高压液相色谱 气相色谱 尿检测
原文传递
加替沙星眼用凝胶不同点眼频次兔眼组织药代动力学比较
18
作者 王小桐 赵欣 +3 位作者 祖薇 沈旭 陈世超 杨强 《中华实验眼科杂志》 CAS CSCD 北大核心 2024年第7期621-628,共8页
目的建立一种测定兔眼组织中加替沙星浓度的方法,并比较加替沙星眼用凝胶兔眼单次和多次点眼后在眼组织及血浆中的药代动力学特征。方法取94只健康新西兰兔。任意选取10只新西兰兔不给予任何药物用于空白组织获取,将剩余84只按照随机数... 目的建立一种测定兔眼组织中加替沙星浓度的方法,并比较加替沙星眼用凝胶兔眼单次和多次点眼后在眼组织及血浆中的药代动力学特征。方法取94只健康新西兰兔。任意选取10只新西兰兔不给予任何药物用于空白组织获取,将剩余84只按照随机数字表法随机分成单次给药组36只和多次给药组48只,雌雄各半,均取左眼为实验眼。单次给药组左眼给予1滴加替沙星眼用凝胶,分别于点眼后0.5、1、3、5、7、10 h收集泪液后进行心脏取血并处死,分别取房水、结膜、角膜、巩膜、虹膜-睫状体、晶状体、玻璃体、视网膜和脉络膜;多次给药组左眼每次给予1滴加替沙星眼用凝胶,每天3次,分别于连续给药第4和第6天首次给药后0.5 h,第7天首次给药后0.5、1、3、5、7、10 h进行心脏取血和眼组织收集。采用甲醇沉淀蛋白法预处理各样本,采用高效液相色谱串联质谱法测定并计算实验兔血浆及眼组织中加替沙星的达峰浓度(C_(max))、达峰时间(T_(max))、曲线下面积(AUC)等药代动力学参数,流动相采用甲醇-0.1%乙酸水溶液(体积比=70∶30),采用正离子多反应检测模式,以环丙沙星为内标物,并参照《中国药典》(2020年版)9012生物样品定量分析方法验证指导原则对方法的选择性、标准曲线和定量下限、准确度和精密度、提取回收率和基质效应、稳定性进行验证。结合加替沙星对眼部常见感染菌的最小抑菌浓度(MIC_(90)),计算各组织和血浆C_(max)/MIC_(90)和AUC/MIC_(90)值。结果加替沙星在各眼组织和血浆中线性关系良好;角膜组织中的日间准确度为-1.5%~6.0%,日间精密度≤15%;角膜组织中的提取回收率为92.0%~94.8%,经内标归一化计算得到的低、中、高浓度的基质效应精密度均不大于3.3%,单次给药后加替沙星在眼前节和后节组织均有较高的药物浓度分布,AUC 0-t从高到低分别为泪液、角膜、结膜、虹膜-睫状体、巩膜、房水、脉络膜、视网膜、晶状体和玻璃体,C_(max)分别为94.90μg/g、7.34μg/g、3.65μg/g、1.81μg/g、1.75μg/g、1.31μg/ml、0.86μg/g、0.53μg/g、0.13μg/g、0.07μg/ml,除晶状体、脉络膜和玻璃体液中的T_(max)为0.5 h,其余各组织T_(max)均为1 h。多次给药第4、6、7天的0.5 h各眼部组组织中加替沙星浓度比较,差异无统计学意义(P>0.05),且角膜、结膜和巩膜中AUC_(0-t)约为单次给药的2.04、2.12和2.32倍。单、多次给药后进入体循环的加替沙星浓度均低于25.00 ng/ml。对于金黄色葡萄球菌和表皮葡萄球菌,加替沙星眼用凝胶连续用药后在眼前节结膜、角膜、巩膜、虹膜-睫状体、房水和脉络膜中的药代动力学/药效学均可满足C_(max)/MIC_(90)≥10且AUC/MIC_(90)≥30。结论成功构建快速灵敏的眼组织加替沙星浓度测量方法。加替沙星眼用凝胶以每天3次点眼连续用药3 d后眼组织可达到稳态浓度,且比单次给药在眼组织浓度升高。局部使用加替沙星眼用凝胶可实现眼部结膜、角膜、巩膜、虹膜-睫状体常见感染细菌的有效治疗。 展开更多
关键词 加替沙星 眼用凝胶 高效液相色谱串联质谱法 药代动力学
下载PDF
基于多组分定量联合主成分分析正交偏最小二乘法-判别分析及熵权优劣解距离法的抗菌消炎胶囊质量差异性评价
19
作者 施丹萍 沈敏 +1 位作者 俞振伟 钟琳 《中国药物与临床》 CAS 2024年第12期749-755,F0003,共8页
目的建立主成分分析(PCA)、正交偏最小二乘法-判别分析(OPLS-DA)及熵权优劣解距离法(EW-TOPSIS)评价抗菌消炎胶囊的多组分质量差异。方法采用高效液相色谱法(HPLC)同时测定15批抗菌消炎胶囊中獐牙菜苦苷、獐牙菜苷、绿原酸、3,5-二-O-... 目的建立主成分分析(PCA)、正交偏最小二乘法-判别分析(OPLS-DA)及熵权优劣解距离法(EW-TOPSIS)评价抗菌消炎胶囊的多组分质量差异。方法采用高效液相色谱法(HPLC)同时测定15批抗菌消炎胶囊中獐牙菜苦苷、獐牙菜苷、绿原酸、3,5-二-O-咖啡酰奎宁酸、知母皂苷BⅡ、知母皂苷AⅢ、原百部碱、对叶百部碱、黄芩苷、汉黄芩苷、黄芩素和汉黄芩素的含量,借助PCA、OPLS-DA及EW-TOPSIS模型对15批消炎胶囊样品进行质量差异分析,筛选出导致差异的特征成分,并进行质量排序。结果12种成分在各自范围内呈现良好的线性关系(r>0.999),平均加样回收率(n=9)96.90%~100.23%(RSD<2.0%)。化学计量学筛选出2个主成分,方差贡献率累计达95.172%;OPLS-DA发掘出黄芩苷、绿原酸、知母皂苷BⅡ和对叶百部碱对抗菌消炎胶囊质量有显著影响;EW-TOPSIS分析结果显示Ci值0.0827~0.8495,15批样品质量差异较大。结论所建立的方法可用于抗菌消炎胶囊质量的综合评价。 展开更多
关键词 色谱法 高压液相 主成分分析 最小二乘法分析 抗菌消炎胶囊
下载PDF
盐酸米诺环素胶囊在中国健康受试者中生物等效性研究
20
作者 冯心成 吕炯贤 +7 位作者 苏畅 黄超超 孙泓 陈海娇 程旻露 丁珏芳 丁黎 苏钰文 《医药导报》 CAS 北大核心 2024年第10期1545-1551,共7页
目的评价2种盐酸米诺环素胶囊空腹和餐后状态下在中国健康人群中生物等效性。方法生物等效性试验采用随机、开发、两周期、自身交叉的设计,健康受试者56例,空腹和餐后各半,每周期单次给予参比制剂或受试制剂50 mg,清洗期为7 d。应用高... 目的评价2种盐酸米诺环素胶囊空腹和餐后状态下在中国健康人群中生物等效性。方法生物等效性试验采用随机、开发、两周期、自身交叉的设计,健康受试者56例,空腹和餐后各半,每周期单次给予参比制剂或受试制剂50 mg,清洗期为7 d。应用高效液相色谱-串联质谱法测定人血浆中米诺环素浓度,计算其药动学参数并评价受试制剂与参比制剂的生物等效性。结果空腹口服米诺环素受试制剂和参比制剂后,米诺环素峰浓度(C_(max))分别为(541±137)和(558±140)ng·mL^(-1),血药浓度-时间曲线下面积(AUC_(0-t))分别为(8347±1986)和(8205±1790)h·ng·mL^(-1),半衰期(t 1/2)分别为(18.2±2.84)和(18.0±3.05)h。餐后口服米诺环素受试制剂和参比制剂后,米诺环素C_(max)分别为(349±72.1)和(352±73.2)ng·mL^(-1),AUC_(0-t)分别为(6428±1077)和(6588±1118)h·ng·mL^(-1),t 1/2分别为(18.5±3.10)和(18.4±3.21)h。在空腹试验中两制剂的C_(max)、AUC_(0-t)和AUC_(0-∞)几何均值比值的90%置信区间分别为(90.84%,101.46%)、(95.2%,102.8%)和(95.31%,102.71%)。在餐后试验中受试制剂和参比制剂的C_(max)、AUC_(0-t)、AUC_(0-∞)几何均值比值的90%置信区间分别为(94.71%,103.42%)、(95.40%,99.83%)和(95.79%,100.02%)。结论中国健康人群在空腹和餐后状态下口服米诺环素2种制剂生物等效。 展开更多
关键词 米诺环素 生物等效性 高效液相色谱-串联质谱法 药动学
下载PDF
上一页 1 2 123 下一页 到第
使用帮助 返回顶部